Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Defense was posted on October 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

ALBUTEROL SULFATE INHA

Closed
SPE2DP-26-T-5338Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

Solicitation SPE2DP-26-T-5338 is a Request for Quotations issued by the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Albuterol Sulfate Inhalation Solution 0.083%. The requirement is for two packages of 3 ml unit doses, with each package containing 25 units, identified by NSN 6505-01-258-0960 and manufacturer part number NDC00487-9501-25 from Nephron Pharmaceuticals Corporation. This FDA-regulated drug is classified as a Type I Code J item with a non-extendable shelf life of 15 months. Delivery is required within 20 days after receipt of order, with FOB, inspection, and acceptance all set at the destination. The contract mandates strict adherence to Medical Marking Standard No. 1, which supersedes MIL-STD-129, and requires packaging to be commercial and sealed to prevent damage. All shipments must comply with MIL-STD-2073-1 and include passive RFID tags for depot stock. Additionally, the contractor must ensure that no mercury or mercury-containing compounds are intentionally added to the supplies. Administrative requirements include the use of the Wide Area WorkFlow system for invoicing and compliance with various FAR and DFARS clauses, including those regarding the safeguarding of covered defense information and the Buy American Act. Quotes must be submitted electronically via the DIBBS portal.

General Info

DLA procurement of Albuterol Sulfate Inhalation Solution from Nephron Pharmaceuticals Corporation via DIBBS.

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Place of Performance

DEU

Set-Aside

NONE

Documents

1
PDF, High priority: read this first21 pages · rfq
High

Read the document

Every page of every file, in your free workspace.

Read the document

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

View Full Breakdown

This one is closed. Find the next one like it.

Open contracts like this one, right now:

  • Sodium Chloride 0.9% Injection SupplierOpen now, due in 7 days
  • Supply of Surgical Detergent (Chlorhexidine Gluconate)Open now, due in 7 days
See open contracts like this

Ask CLEATUS

I've read this contract. Ask me anything.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA

Full Description

Show more
ALBUTEROL SULFATE INHALATION SOLUTION
ALBUTEROL SULFATE INHALATION SOLUTION,0.083%,
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
3 ML, UNIT DOSE, 25'S
NEPHRON PHARM. NDC00487-9501-25
STD AAC L; U/I "PG" (3X25)
FSSB EVE RETTANO 6/11/13
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO Sign up to see this detail. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 PG = 25 EA
SPE2DP-26-T-5338
SECTION B
MERCURY OR MERCURY CONTAINING COMPOUNDS SHALL
NOT BE INTENTIONALLY ADDED TO<(>,<)> OR COME IN DIRECT
CONTACT WITH<(>,<)> ANY HARDWARE OR SUPPLIES FURNISHED
UNDER THIS CONTRACT. EXCEPTION: FUNCTIONAL MERCURY
USED IN BATTERIES, FLUORESCENT LIGHTS, REQUIRED
INSTRUMENTS; SENSORS OR CONTROLS; WEAPON SYSTEMS;
AND CHEMICAL ANALYSIS REAGENTS SPECIFIED BY NAVSEA.
PORTABLE FLUORESCENT LAMPS AND PORTABLE INSTRUMENTS
CONTAINING MERCURY SHALL BE SHOCK PROOF AND CONTAIN
A SECOND BOUNDARY OF CONTAINMENT OF THE MERCURY OR
MERCURY COMPOUND. (IAW NAVSEA 5100-003D).
RS012: Shelf-life requirement RS001 for a TYPE I (CODE J) item with a shelf life of 15 months (non-extendable) applies to this item.
NEPHRON PHARMACEUTICALS CORPORATION 0TU69 P/N NDC00487-9501-25
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7018540376 0001 PG 2.000
NSN/MATERIAL:6505012580960
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-258-0960 Quantity: 2 PG Purchase Request: 7018540376QTY: 2 Delivery: 20 days ADO

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS